Form 4: Elevance Health EVP & CFO Mark Kaye Reports Stock Transaction
SEC Form 4 Filing
Mark Kaye, EVP & CFO of Elevance Health, reports the disposition of 2,818 shares of common stock to cover tax liabilities related to vesting restricted stock.
Summary
- On October 2, 2024, Mark Kaye, the EVP & CFO of Elevance Health, Inc. disposed of 2,818 shares of common stock.
- The transaction was executed to cover tax liabilities associated with the vesting of previously granted restricted stock.
- The shares were disposed of at a price of $505.16 per share.
- Following the transaction, Kaye directly owns 20,213 shares of Elevance Health common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a routine transaction. It doesn't indicate positive or negative sentiment about the company's performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC when company insiders, like the CFO, trade their company's stock. It provides transparency to the market regarding the transactions of company executives.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax liabilities.
Key Dates
| Date | Description |
|---|---|
| 10/02/2024 | Date of stock transaction (disposition of shares). |
| 10/04/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.